Cargando…
Eosinophils Target Therapy for Severe Asthma: Critical Points
Asthma is a chronic and heterogeneous disease, which is defined as severe disease whenever it requires treatment with a high dose of inhaled corticosteroids plus a second controller and/or systemic corticosteroids to prevent it from becoming ‘‘uncontrolled” or if it remains ‘‘uncontrolled” despite t...
Autores principales: | Brussino, L., Heffler, E., Bucca, C., Nicola, S., Rolla, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222236/ https://www.ncbi.nlm.nih.gov/pubmed/30498762 http://dx.doi.org/10.1155/2018/7582057 |
Ejemplares similares
-
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022) -
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021) -
Is it severe asthma or asthma with severe comorbidities?
por: Brussino, Luisa, et al.
Publicado: (2017) -
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
por: Solidoro, Paolo, et al.
Publicado: (2019) -
Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)